These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Self-assessment mini-program. Osment LS Int J Dermatol; 1978; 17(1):65-6. PubMed ID: 627443 [No Abstract] [Full Text] [Related]
27. Childhood epidermolysis bullosa acquisita. Detection in a 5-year-old girl. Rubenstein R; Esterly NB; Fine JD Arch Dermatol; 1987 Jun; 123(6):772-6. PubMed ID: 3555356 [TBL] [Abstract][Full Text] [Related]
28. The immunopathology of epidermolysis bullosa acquisita. Kushniruk W Can Med Assoc J; 1973 May; 108(9):1143-6. PubMed ID: 4574408 [TBL] [Abstract][Full Text] [Related]
29. Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer. Furue M; Iwata M; Yoon HI; Kubota Y; Ohto H; Kawashima M; Tsuchida T; Oohara K; Tamaki K; Kukita A J Am Acad Dermatol; 1986 May; 14(5 Pt 2):873-8. PubMed ID: 3086389 [TBL] [Abstract][Full Text] [Related]
30. Cyclosporine A in epidermolysis bullosa acquisita. Zachariae H J Am Acad Dermatol; 1987 Dec; 17(6):1058-9. PubMed ID: 3429719 [No Abstract] [Full Text] [Related]
32. Clearing of epidermolysis bullosa acquisita with cyclosporine. Layton AM; Cunliffe WJ J Am Acad Dermatol; 1990 Mar; 22(3):535-6. PubMed ID: 2312839 [No Abstract] [Full Text] [Related]
33. Treatment of epidermolysis bullosa acquisita with cyclosporine. Connolly SM; Sander HM J Am Acad Dermatol; 1987 Apr; 16(4):890. PubMed ID: 3571559 [No Abstract] [Full Text] [Related]
34. Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus. Boh E; Roberts LJ; Lieu TS; Gammon WR; Sontheimer RD J Am Acad Dermatol; 1990 Apr; 22(4):587-93. PubMed ID: 2319019 [TBL] [Abstract][Full Text] [Related]
35. Intractable epidermolysis bullosa acquisita: efficacy of cyclosporin A. Merle C; Blanc D; Zultak M; van Landuyt H; Drobacheff C; Laurent R Dermatologica; 1990; 181(1):44-7. PubMed ID: 2394303 [TBL] [Abstract][Full Text] [Related]
36. Identification of the epidermolysis bullosa acquisita antigen by LH 7.2 monoclonal antibody: use in diagnosis. Tatnall FM; Whitehead PC; Black MM; Wojnarowska F; Leigh IM Br J Dermatol; 1989 Apr; 120(4):533-9. PubMed ID: 2730844 [TBL] [Abstract][Full Text] [Related]
38. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)]. Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283 [TBL] [Abstract][Full Text] [Related]
39. [The effect of collagenase inhibition on bullous eruption and healing process in epidermolysis bullosa]. Coradello H; Lubec G Hautarzt; 1979 Feb; 30(2):89-91. PubMed ID: 217851 [TBL] [Abstract][Full Text] [Related]
40. Self-initiated use of topical cannabidiol oil for epidermolysis bullosa. Chelliah MP; Zinn Z; Khuu P; Teng JMC Pediatr Dermatol; 2018 Jul; 35(4):e224-e227. PubMed ID: 29786144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]